Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Neuroscience CAG for Alzheimer's Disease

NCT07118137 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT07118137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07118137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Neuroscience CAG for Alzheimer's Disease
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2023
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, magnetic resonance imaging, memory impairment, neurodegenerative diseases